Solid oral dosage forms
Tablets and capsules. Tell us the API, strength, development stage and target market.
Finished dosage-form development
Development and manufacturing partnerships for tablets, capsules, injectables, liquids and semi-solids. Hanpars coordinates the project; partners manufacture.
We run the project. Partners run the plant.
Formulation, analytical work, scale-up, stability, packaging and technology transfer rarely sit under one roof. Hanpars coordinates them across development and manufacturing partners, with the target market's regulatory requirements in view from the first batch.
Hanpars does not own a plant, does not hold a GMP certificate for one, and cannot guarantee a regulatory outcome. We offer the coordination, the partner network and the dossier.
Dosage forms we take on
Injectable preparations
Ampoules and vials. Include the formulation, presentation, project status and documentation needs.
Liquids and semi-solids
Oral liquids and topical preparations. Start with the formulation scope and intended use.
What we ask at the first meeting
The activities and partners depend on the answers, so we start here.
The product
API, dosage form, strength and intended presentation.
The stage
Existing formulation, dossier, technical data and development status.
The market
Where it will be registered, and what that authority will require.
The support
Formulation, scale-up, technology transfer, or a defined partner activity.
Tell us where the project stands.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.
Telephone+98 21 8885 6347 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com